
← Fixing Healthcare Podcast21 okt · 39 min
FHC #232: Can GLP-1s & GenAI solve healthcare’s affordability crisis?
American healthcare keeps getting more expensive. Insurers respond by restricting access, employers cut benefits and patients pay more out of pocket. Yet the underlying problem remains: chronic diseases continue to drive much of the nation’s medical spending.
In this episode of Diving Deep, co-hosts Dr. Robert Pearl and Jeremy Corr explore two technological advances that could help break this cycle. One is already changing how millions of Americans manage their weight. The other could transform how physicians and patients manage chronic disease.
Together, Pearl argues, GLP-1 medications and generative AI offer a new path toward better health and more affordable care.
Two innovations, one goal: preventing costly complications
Pearl begins with a striking figure: Americans now spend more than $5.7 trillion annually on healthcare, with chronic diseases accounting for much of the expense. Five major conditions (obesity, diabetes, cardiovascular disease, cancer and dementia) are associated with more than $1.3 trillion in annual medical costs.
Rather than continuing to shift these expenses among insurers, employers and patients, Pearl argues that medicine should focus on preventing the complications that generate them.
GLP-1 medications offer one way forward. By helping patients lose substantial weight, these drugs can also reduce the risk of diabetes and other obesity-related conditions. Clinical trials demonstrate benefits that extend well beyond the number on the scale.
But prevention alone isn’t enough. Millions of Americans already live with hypertension, diabetes and heart failure. Despite effective treatments, many struggle to control their conditions because medical care still revolves around brief office visits every few months.
Pearl explains how GenAI agents, connected to home-monitoring devices, could change that. Rather than waiting until a patient’s next appointment, AI could analyze daily blood-pressure readings, glucose levels and weight changes, identify worsening conditions and alert clinicians when treatment needs adjusting.
The result would be more continuous care, fewer preventable complications and potentially billions in savings. Making that vision possible, however, would require lower drug prices, compatible monitoring technology and payment models that reward keeping patients healthy.
What a troubling AI experiment reveals about medicine’s future
The second half of the episode explores a very different development: an OpenAI ex